An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
Clinical trial NCT05514873 · COMPLETED
Trial details
- NCT number
- NCT05514873
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2024-03-13
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.